Intensive multidisciplinary weight management in patients with type 1 diabetes and obesity: A one-year retrospective matched cohort study

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

(2017) John R Petrie et al.   Lancet Diabetes & Endocrinology

Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials

(2016) Kathrin Herrmann et al.   ADVANCES IN THERAPY

9. Cardiovascular Disease and Risk Management

(2016)   DIABETES CARE

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)

(2015) Philip D. Home et al.   DIABETES CARE

A systematic review and meta-analysis of exercise interventions in adults with type 1 diabetes

(2014) Jane E. Yardley et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic Registry

(2013) J. H. Simmons et al.   DIABETES CARE

The Effect of Excess Weight Gain With Intensive Diabetes Mellitus Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes Mellitus

(2012) Jonathan Q. Purnell et al.   CIRCULATION

The broad clinical phenotype of Type 1 diabetes at presentation

(2012) S. R. Merger et al.   DIABETIC MEDICINE

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

(2012) Simon Heller et al.   LANCET

Temporal patterns in overweight and obesity in Type 1 diabetes

(2010) B. Conway et al.   DIABETIC MEDICINE

Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration

(2009)   ARCHIVES OF INTERNAL MEDICINE

Diabetes medications and body weight

(2009) Joanna Mitri et al.   Expert Opinion On Drug Safety

The why WAIT program: Improving clinical outcomes through weight management in type 2 diabetes

(2008) Osama Hamdy et al.   Current Diabetes Reports

Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVETM study

(2008) A. Dornhorst et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE